Recipients Chosen for Their Dedication to Patients and Commitment to Advancing Pharmacy Care
Maple Grove, MN – February 8, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are pleased ... Read More
Now Offers Commercially Insured Patients $0 Copay and Free Home Delivery for Acute and Preventive Migraine Treatment Options
Maple Grove, MN – February 1, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that commercially insured migraine ... Read More
Osaka, Japan – January 28, 2021 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) announced that it has entered into an exclusive development and marketing agreement with Neurolief Ltd. (Neurolief, ... Read More
Maple Grove, MN – December 15, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Ramelteon Tablets, 8 mg. Upsher-Smith’s product is AB-rated to the branded product, ROZEREM® (ramelteon) tablets.* Ramelteon tablets are ... Read More
Maple Grove, MN – December 7, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that as part of its ongoing effort to reimagine prescriber education during the COVID-19 pandemic, it has launched a new and ... Read More
Tosymra®(sumatriptan nasal spray) 10 mg and Zembrace® SymTouch® (sumatriptan injection) 3 mg to be Featured at Virtual Exhibit Booth
Maple Grove, MN – November 16, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will ... Read More